SCHEMBL6950467

SCHEMBL6950467

CC(Br)C1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4182682 0.97
SCHEMBL30895678 0.97
SCHEMBL909432 0.97
SCHEMBL8217354 0.94 SHBG (0.42)
SCHEMBL7022582 0.93
SCHEMBL704637 0.86
SCHEMBL7777503 0.86
SCHEMBL6711919 0.83
SCHEMBL1071137 0.75 ALDH1A1 (0.30)
SCHEMBL23595592 0.74 SHBG (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260070887-A1 AMIDE OR UREA COMPOUND SHENZHEN ZHONGGE BIOLOGICAL TECH CO LTD (CN) 2026-03-12 US disclosed
EP-4628486-A1 AMIDE OR UREA COMPOUND Shenzhen Zhongge Biological Technology Co., Ltd. (CN) 2025-10-08 EP disclosed
WO-2024114787-A9 AMIDE OR UREA COMPOUND 深圳众格生物科技有限公司 2025-05-30 WO disclosed
CN-116102537-B Quinolinone derivative and preparation method and application thereof 四川大学 2024-10-01 CN disclosed
WO-2024114787-A1 AMIDE OR UREA COMPOUND 深圳众格生物科技有限公司 2024-06-06 WO disclosed
CN-116102537-A Quinolinone derivative and preparation method and application thereof 四川大学 2023-05-12 CN disclosed
EP-1181286-B1 3-(ARYLSULFONYLAMINO)-TETRAHYDROPYRAN-3-CARBOXYLIC ACID HYDROXAMIDES PFIZER PROD INC (US) 2003-11-12 EP disclosed
EP-1181285-B1 3-(ARYLSULFONYLAMINO)-TETRAHYDROFURAN-3-CARBOXYLIC ACID HYDROXAMIDES PFIZER PROD INC (US) 2003-10-08 EP disclosed
EP-0977733-B1 ARYLSULFONYLAMINO HYDROXAMIC ACID DERIVATIVES PFIZER PROD INC (US) 2003-09-03 EP disclosed
EP-1070058-B1 (4-ARYLSULFONYLAMINO)-TETRAHYDROPYRAN-4-CARBOXYLIC ACID HYDROXAMIDES PFIZER PROD INC (US) 2003-05-02 EP disclosed
EP-1070058-A1 (4-ARYLSULFONYLAMINO)-TETRAHYDROPYRAN-4-CARBOXYLIC ACID HYDROXAMIDES Pfizer Products Inc. (US) 2001-01-24 EP disclosed
WO-2000073295-A1 3-(ARYLSULFONYLAMINO)-TETRAHYDROPYRAN-3-CARBOXYLIC ACID HYDROXAMIDES PFIZER PRODUCTS INC. (US) 2000-12-07 WO disclosed
WO-2000073294-A2 3-(ARYLSULFONYLAMINO)-TETRAHYDROFURAN-3-CARBOXYLIC ACID HYDROXAMIDES PFIZER PRODUCTS INC. (US) 2000-12-07 WO disclosed
US-6087392-A A METALLOPROTEINASE INHIBITORS FOR INHIBITING MAMMALIAN REPROLYSIN PFIZER INC. (US) 2000-07-11 US disclosed
EP-0977733-A1 ARYLSULFONYLAMINO HYDROXAMIC ACID DERIVATIVES Pfizer Products Inc. (US) 2000-02-09 EP disclosed
WO-1999052889-A1 (4-ARYLSULFONYLAMINO)-TETRAHYDROPYRAN-4-CARBOXYLIC ACID HYDROXAMIDES PFIZER PRODUCTS INC. (US) 1999-10-21 WO disclosed
WO-1998033768-A1 ARYLSULFONYLAMINO HYDROXAMIC ACID DERIVATIVES PFIZER PRODUCTS INC. (US) 1998-08-06 WO disclosed
US-4388459-A HYPOLIPIDEMIC, ANTIATHEROSCLEROTIC AMERICAN CYANAMID COMPANY (US) 1983-06-14 US disclosed
US-4259352-A 4-[Cycloalkyl- or cycloalkenyl-amino(cycloalkyl- or cycloalkenyl-alkenyl)amino]phenyl compounds, useful as hypolipidemic and antiatherosclerotic agents AMERICAN CYANAMID COMPANY (US) 1981-03-31 US disclosed
EP-0003663-A2 Amino-substituted phenyl and heteroaryl compounds, process for their preparation and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1979-08-22 EP disclosed